These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 22358428)
1. Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. Soussan M; Des Guetz G; Barrau V; Aflalo-Hazan V; Pop G; Mehanna Z; Rust E; Aparicio T; Douard R; Benamouzig R; Wind P; Eder V Eur Radiol; 2012 Jul; 22(7):1479-87. PubMed ID: 22358428 [TBL] [Abstract][Full Text] [Related]
2. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
3. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET. Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481 [TBL] [Abstract][Full Text] [Related]
4. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Michielsen K; Vergote I; Op de Beeck K; Amant F; Leunen K; Moerman P; Deroose C; Souverijns G; Dymarkowski S; De Keyzer F; Vandecaveye V Eur Radiol; 2014 Apr; 24(4):889-901. PubMed ID: 24322510 [TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients. Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Kassai Y; Yui M; Matsumoto S; Sugimura K Eur J Radiol; 2015 Nov; 84(11):2321-31. PubMed ID: 26231045 [TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700 [TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT. Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549 [TBL] [Abstract][Full Text] [Related]
8. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Song I; Kim SH; Lee SJ; Choi JY; Kim MJ; Rhim H Br J Radiol; 2012 May; 85(1013):577-86. PubMed ID: 21343320 [TBL] [Abstract][Full Text] [Related]
9. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT. Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168 [TBL] [Abstract][Full Text] [Related]
10. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [TBL] [Abstract][Full Text] [Related]
11. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy. Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Heusner TA; Kuemmel S; Koeninger A; Hamami ME; Hahn S; Quinsten A; Bockisch A; Forsting M; Lauenstein T; Antoch G; Stahl A Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1077-86. PubMed ID: 20204355 [TBL] [Abstract][Full Text] [Related]
15. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125. Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509 [TBL] [Abstract][Full Text] [Related]
17. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. van Ufford HM; Kwee TC; Beek FJ; van Leeuwen MS; Takahara T; Fijnheer R; Nievelstein RA; de Klerk JM AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511 [TBL] [Abstract][Full Text] [Related]
18. Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. Cafagna D; Rubini G; Iuele F; Maggialetti N; Notaristefano A; Pinto D; Niccoli-Asabella A; Palmiotti G; Lasciarrea M; Maggialetti A Radiol Med; 2012 Mar; 117(2):293-311. PubMed ID: 21744252 [TBL] [Abstract][Full Text] [Related]
19. Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer. Park SH; Moon WK; Cho N; Chang JM; Im SA; Park IA; Kang KW; Han W; Noh DY Eur Radiol; 2012 Jan; 22(1):18-25. PubMed ID: 21845462 [TBL] [Abstract][Full Text] [Related]
20. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]